相关实验视频
Updated: Jan 10, 2026

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
40.0K
针对OxLDL的化学抗原受体T调节细胞减少动脉硬化斑块的发展
Robert D Schwab1, David Degaramo2, Seok Jae Hong3
1Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Circulation
|November 21, 2025
概括
化学抗原受体T调节细胞 (CAR Tregs) 向氧化LDL (OxLDL) 减少泡细胞的形成并抑制动脉样硬化斑块的形成. 这种新疗法通过缓解炎症为动脉样硬化提供了潜在的新疗法.
科学领域:
- 免疫学
- 心血管研究
- 细胞治疗
背景情况:
- 动脉样硬化每年造成1800万人死亡,
- 氧化LDL驱动炎症和泡细胞的形成,这是动脉样硬化斑块的关键.
- 目前的治疗方法缺乏针对性抗炎方法来治疗动脉样硬化,
研究的目的:
- 开发和评估一种抗OxLDL特异性化学抗原受体T细胞调节疗法 (CAR Treg).
- 在体外和体内评估CAR Tregs在缓解炎症和泡细胞形成方面的有效性.
主要方法:
- 创建了一个可诱导的Treg平台,用于抗OxLDLCARTreg生成.
- 在实验室中评估免疫抑制和泡细胞减少.
- 在超脂血症和动脉样硬化小鼠模型中测试小鼠抗OxLDLCAR Tregs.
主要成果:
- 在体外,抗OxLDLCAR Tregs有效降低了巨细胞泡的形成.
- 在体内观察到显著抑制动脉样斑块的形成.
- 在免疫能力较强的小鼠模型中,CAR Tregs 显示出有效性.
结论:
- 抗OxLDLCAR Tregs可以缓解由OxLDL引起的炎症和斑块沉积.
- 这种CAR Treg疗法代表了对动脉样硬化的有前途的新疗法.
- 用CAR Tregs向OxLDL为目前无法接受干预的患者提供了潜在的治疗方法.
相关概念视频
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Atherosclerosis I: Introduction
835
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835
Inflammation
61.5K
Overview
61.5K

